Chlorhexidine baths lower MRSA acquisition in ICU, study says

02/18/2014 |

The rate of MRSA acquisition decreased 20.68% after ICU patients were given daily baths using a chlorhexidine-based soap, compared with no significant changes in a control unit, researchers reported in the journal Infection Control and Hospital Epidemiology. The study found a 20.77% decline in all S. aureus infections in the intervention unit.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI